p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans (Q36386468)

13 August 2017

p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans (English)

1 reference

13 August 2017

7

Aurelia Noske

0 references

Kristian Ikenberg

2

object named as

Kristian Ikenberg

0 references

Holger Moch

12

object named as

Holger Moch

1 reference

13 August 2017

Peter J Wild

1

1 reference

13 August 2017

Thomas J Fuchs

3

1 reference

13 August 2017

Markus Rechsteiner

4

1 reference

13 August 2017

Strahil Georgiev

5

1 reference

13 August 2017

Niklaus Fankhauser

6

1 reference

13 August 2017

Matthias Roessle

8

1 reference

13 August 2017

Rosmarie Caduff

9

1 reference

13 August 2017

Athanassios Dellas

10

1 reference

13 August 2017

Daniel Fink

11

1 reference

13 August 2017

Wilhelm Krek

13

1 reference

13 August 2017

Ian J Frew

14

1 reference

13 August 2017

8 June 2012

1 reference

13 August 2017

EMBO Molecular Medicine

1 reference

13 August 2017

4

1 reference

13 August 2017

8

1 reference

13 August 2017

808-824

1 reference

High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

30 September 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

A proposed model for endometrial serous carcinogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

30 September 2017

p53-based cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Revised FIGO staging for carcinoma of the endometrium

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Insights into endometrial serous carcinogenesis and progression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting Its Precancer Nature for Endometrial Serous Carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Endometrial glandular dysplasia and endometrial intraepithelial neoplasia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Endometrial carcinoma: pathology and genetics.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Precursors of endometrial clear cell carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Co-expression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: an immunohistochemical study of 19 cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Tissue microarrays for high-throughput molecular profiling of tumor specimens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Molecular characterization of uterine clear cell carcinoma

28 June 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Immunophenotyping of serous carcinoma of the female genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Pax8: a marker for carcinoma of Müllerian origin in serous effusions.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

21 September 2018

Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients

21 January 2018

1 reference

12 December 2020

Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features

1 reference

12 December 2020

p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus

1 reference

12 December 2020

Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components

1 reference

12 December 2020

Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors

1 reference

12 December 2020

Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies

1 reference

12 December 2020

PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia

1 reference

12 December 2020

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

12 December 2020

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

1 reference

12 December 2020

Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma

1 reference

12 December 2020

Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1002/EMMM.201101063

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

22678923

1 reference